Publications by authors named "Ian Lockart"

Claim this Profile
A
Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy-A cross-sectional study.
Joga Chaganti, Georgia Zeng, Adwaita Patil, Ian Lockart, Michelle Dellalana

Hepatology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Herald Bleed-A Fortunate Endoscopic Diagnosis of an Aorto-Duodenal Fistula Secondary to a Mycotic Aortic Aneurysm With Abscess Formation.
Arteen Arzivian, Robert O'Neill, Ian Lockart

Clin Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy.
Georgia Zeng, Shivani Krishnamurthy, Ananda Staats Pires, Anna Guller, Joga Chaganti, Ian Lockart

Hepatol Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease.
Ivan Shen, Jana Stojanova, Malcolm Yeo, Nick Olsen, Ian Lockart

Br J Clin Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia.
Yuen Kang Joseph Yeoh, Gregory J Dore, Ian Lockart, Mark Danta, Ciara Flynn

Intern Med J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE.
Joga Chaganti, Georgia Zeng, Nway Tun, Ian Lockart, Christina Abdelshaheed

Hepatol Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective internal radiation therapy for hepatocellular carcinoma: A 15-year multicenter Australian cohort study.
David Stephen Prince, Glen Schlaphoff, Scott Anthony Davison, Ya Ruth Huo, Hao Xiang, Ian Lockart

J Gastroenterol Hepatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.
Ian Lockart, Malcolm G H Yeo, Behzad Hajarizadeh, Gregory J Dore, Mark Danta

Hepatology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.
Ian Lockart, Behzad Hajarizadeh, Niamh Buckley, Scott Davison, Emilia Prakoso

J Gastroenterol Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply.
Mark Danta, Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed

Aliment Pharmacol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed, Mark Danta

Aliment Pharmacol Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival.
Ian Lockart, Behzad Hajarizadeh, Maryam Alavi, Scott Davison, Emilia Prakoso

J Viral Hepat· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma.
Sichan He, Ian Lockart, Maryam Alavi, Mark Danta, Behzad Hajarizadeh

Aliment Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers.
Marianne F Weber, Henry M Marshall, Nicole Rankin, Stephen Duffy, Kwun M Fong, Ian Lockart

Public Health Res Pract· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.
Ian Lockart, Gail V Matthews, Mark Danta

Curr Opin Infect Dis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migration route of Fasciola into the liver.
Ian Lockart, Amitabha Das, Neil D Merrett, Miriam T Levy

JGH Open· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and associations of recent physical intimate partner violence among women attending an Australian sexual health clinic.
Ian Lockart, Nathan Ryder, Anna M McNulty

Sex Transm Infect· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is screening asymptomatic men who have sex with men for urethral gonorrhoea worthwhile?
Nathan Ryder, Ian G Lockart, Chris Bourne

Sex Health· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis